Patents by Inventor Ryan Swanson

Ryan Swanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND USES OF VARIANT CD80 FUSION PROTEINS AND RELATED CONSTRUCTS
    Publication number: 20220177587
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: September 19, 2019
    Publication date: June 9, 2022
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Mark F. MAURER, Stanford L. PENG, Jing YANG, Kristine M. SWIDEREK
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20220162319
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: February 2, 2022
    Publication date: May 26, 2022
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20220153846
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: February 2, 2022
    Publication date: May 19, 2022
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER
  • Immunomodulatory proteins with tunable affinities
    Patent number: 11319359
    Abstract: Provided are immunomodulatory proteins and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: May 3, 2022
    Assignee: Alpine Immune Sciences, Inc.
    Inventors: Ryan Swanson, Michael Kornacker
  • VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS
    Publication number: 20220112265
    Abstract: Provided herein are immunomodulatory proteins comprising ICOSL variants and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: December 22, 2021
    Publication date: April 14, 2022
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Lawrence EVANS, Michael KORNACKER, Ryan SWANSON
  • CD80 variant immunomodulatory proteins and uses thereof
    Patent number: 11230588
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: January 25, 2022
    Assignee: Alpine Immune Sciences, Inc.
    Inventors: Ryan Swanson, Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper
  • PD-1 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210363219
    Abstract: Provided herein are immunomodulatory proteins comprising variant PD-1 polypeptides, nucleic acids encoding such proteins and engineered cells expressing such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: June 14, 2019
    Publication date: November 25, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Daniel William DEMONTE
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210347897
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: June 11, 2021
    Publication date: November 11, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER
  • CD80 variant immunomodulatory proteins and uses thereof
    Patent number: 11117950
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: September 14, 2021
    Assignee: Alpine Immune Sciences, Inc.
    Inventors: Ryan Swanson, Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper
  • CD80 variant immunomodulatory proteins and uses thereof
    Patent number: 11117948
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: September 14, 2021
    Assignee: Alpine Immune Sciences, Inc.
    Inventors: Ryan Swanson, Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper
  • CD80 variant immunomodulatory proteins and uses thereof
    Patent number: 11117949
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: September 14, 2021
    Assignee: Alpine Immune Sciences, Inc.
    Inventors: Ryan Swanson, Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper
  • CD80 variant immunomodulatory proteins and uses thereof
    Patent number: 11096988
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: August 24, 2021
    Assignee: Alpine Immune Sciences, Inc.
    Inventors: Ryan Swanson, Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper
  • CD112 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210253668
    Abstract: Provided herein are immunomodulatory proteins comprising variant CD112 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: July 27, 2017
    Publication date: August 19, 2021
    Applicant: ALPINE IMMUNE SCIENCES, INC.
    Inventors: Ryan SWANSON, Michael KORNACKER, Daniel William DEMONTE, Mark F. MAURER, Dan ARDOUREL, Joseph L. KUIJPER
  • CD80 variant immunomodulatory proteins and uses thereof
    Patent number: 11078282
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: August 3, 2021
    Assignee: ALPINE IMMUNE SCIENCES, INC.
    Inventors: Ryan Swanson, Michael Kornacker
  • ICOS LIGAND VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210188995
    Abstract: Provided herein are immunomodulatory proteins comprising ICOSL variants and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: November 24, 2020
    Publication date: June 24, 2021
    Applicant: ALPINE IMMUNE SCIENCES, INC.
    Inventors: Ryan SWANSON, Michael KORNACKER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210188942
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: January 29, 2021
    Publication date: June 24, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210171603
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: January 29, 2021
    Publication date: June 10, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210163571
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: January 28, 2021
    Publication date: June 3, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210155669
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: January 28, 2021
    Publication date: May 27, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210155668
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: January 28, 2021
    Publication date: May 27, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER